Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-07-17 Sale |
2024-07-19 08:29 am |
Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer |
22,528 | $6.4726 | $145,815 | 330,735 (Direct) |
View |
| 2024-07-17 Sale |
2024-07-19 08:28 am |
Candel Therapeutics Inc. | CADL | Schoch Charles See Remarks |
9,884 | $6.4726 | $63,975 | 62,520 (Direct) |
View |
| 2024-07-17 Sale |
2024-07-19 08:26 am |
Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer |
10,875 | $6.4726 | $70,390 | 114,482 (Direct) |
View |
| 2024-07-17 Sale |
2024-07-19 08:24 am |
Candel Therapeutics Inc. | CADL | Barone Francesca Chief Scientific Officer |
14,051 | $6.4726 | $90,947 | 159,961 (Direct) |
View |
| 2024-07-11 Sale |
2024-07-15 08:36 am |
Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer |
13,330 | $5.9734 | $79,625 | 160,900 (Direct) |
View |
| 2024-07-11 Sale |
2024-07-15 08:35 am |
Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer |
20,293 | $5.9734 | $121,218 | 353,263 (Direct) |
View |
| 2024-07-11 Sale |
2024-07-15 08:34 am |
Candel Therapeutics Inc. | CADL | Schoch Charles See Remarks |
8,897 | $5.9734 | $53,145 | 72,404 (Direct) |
View |
| 2024-07-11 Sale |
2024-07-15 08:32 am |
Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer |
9,769 | $5.9734 | $58,354 | 125,357 (Direct) |
View |
| 2024-07-11 Sale |
2024-07-15 08:30 am |
Candel Therapeutics Inc. | CADL | Barone Francesca Chief Scientific Officer |
12,645 | $5.9734 | $75,534 | 174,012 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-26 Option Award |
2024-06-27 08:41 am |
N/A 2034-06-26 |
Candel Therapeutics Inc. | CADL | PAPA JOSEPH C Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-27 08:40 am |
N/A 2034-06-26 |
Candel Therapeutics Inc. | CADL | Nguyen Diem Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-27 08:39 am |
N/A 2034-06-26 |
Candel Therapeutics Inc. | CADL | Nabel Gary J. Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-27 08:39 am |
N/A 2034-06-26 |
Candel Therapeutics Inc. | CADL | Martell Christopher Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-27 08:37 am |
N/A 2034-06-26 |
Candel Therapeutics Inc. | CADL | Manning Paul B Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-27 08:36 am |
N/A 2034-06-26 |
Candel Therapeutics Inc. | CADL | Loggia Nicoletta Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-27 08:35 am |
N/A 2034-06-26 |
Candel Therapeutics Inc. | CADL | Gaeta Renee Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-27 08:34 am |
N/A 2034-06-26 |
Candel Therapeutics Inc. | CADL | Benz Edward J. JR Director |
14,240 | $0 | 14,240 (Direct) |
View |
Ownership |
2024-01-19 08:30 am |
N/A N/A |
Candel Therapeutics Inc. | CADL | Schoch Charles See Remarks |
0 | $0 | 145,799 (Direct) |
View |
| 2023-11-28 Tax Withholding |
2023-11-30 5:00 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer |
17,328 | $0.9 | 174,230 (Direct) |
View |
| 2023-11-28 Tax Withholding |
2023-11-30 5:00 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer |
43,443 | $0.9 | 373,556 (Direct) |
View |
| 2023-11-28 Tax Withholding |
2023-11-30 5:00 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer |
12,175 | $0.9 | 135,126 (Direct) |
View |
| 2023-11-28 Tax Withholding |
2023-11-30 5:00 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Barone Francesca Chief Scientific Officer |
19,748 | $0.9 | 186,657 (Direct) |
View |
| 2023-11-28 Tax Withholding |
2023-11-30 5:00 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Amello Jason Chief Financial Officer |
20,153 | $0.9 | 202,009 (Direct) |
View |
| 2023-11-26 Option Award |
2023-11-28 4:30 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer |
180,108 | $0 | 416,999 (Direct) |
View |
| 2023-11-26 Option Award |
2023-11-28 4:30 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer |
104,516 | $0 | 191,558 (Direct) |
View |
| 2023-11-26 Option Award |
2023-11-28 4:30 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer |
88,822 | $0 | 147,301 (Direct) |
View |
| 2023-11-26 Option Award |
2023-11-28 4:30 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Barone Francesca Chief Scientific Officer |
112,790 | $0 | 206,405 (Direct) |
View |
| 2023-11-26 Option Award |
2023-11-28 4:30 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Amello Jason Chief Financial Officer |
125,717 | $0 | 222,162 (Direct) |
View |
| 2023-06-28 Option Award |
2023-06-29 09:00 am |
N/A 2033-06-28 |
Candel Therapeutics Inc. | CADL | Gaeta Renee Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2023-06-28 Option Award |
2023-06-29 09:00 am |
N/A 2033-06-28 |
Candel Therapeutics Inc. | CADL | Nguyen Diem Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2023-06-28 Option Award |
2023-06-29 09:00 am |
N/A 2033-06-28 |
Candel Therapeutics Inc. | CADL | Manning Paul B Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2023-06-28 Option Award |
2023-06-29 09:00 am |
N/A 2033-06-28 |
Candel Therapeutics Inc. | CADL | Martell Christopher Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2023-06-28 Option Award |
2023-06-29 09:00 am |
N/A 2033-06-28 |
Candel Therapeutics Inc. | CADL | Benz Edward J. JR Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2023-06-28 Option Award |
2023-06-29 09:00 am |
N/A 2033-06-28 |
Candel Therapeutics Inc. | CADL | PAPA JOSEPH C Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2023-06-28 Option Award |
2023-06-29 09:00 am |
N/A 2033-06-28 |
Candel Therapeutics Inc. | CADL | Aguilar-Cordova Estuardo Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2023-06-28 Option Award |
2023-06-29 09:00 am |
N/A 2033-06-28 |
Candel Therapeutics Inc. | CADL | Nabel Gary J. Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 08:45 am |
N/A 2033-06-07 |
Candel Therapeutics Inc. | CADL | Loggia Nicoletta Director |
28,480 | $0 | 28,480 (Direct) |
View |
| 2023-04-28 Option Award |
2023-05-02 5:10 pm |
N/A 2033-04-28 |
Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer |
180,000 | $0 | 180,000 (Direct) |
View |
| 2023-04-28 Option Award |
2023-05-02 5:05 pm |
N/A 2033-04-28 |
Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer |
90,000 | $0 | 90,000 (Direct) |
View |